首页 | 本学科首页   官方微博 | 高级检索  
检索        

狼疮性肾炎患者尿单核-巨噬细胞趋化蛋白-1和转化生长因子-β_1检测的临床意义
引用本文:苏军霞,梁昭红,刘天喜,王荣珍.狼疮性肾炎患者尿单核-巨噬细胞趋化蛋白-1和转化生长因子-β_1检测的临床意义[J].兰州医学院学报,2009,35(3):68-71.
作者姓名:苏军霞  梁昭红  刘天喜  王荣珍
作者单位:兰州大学第一医院,肾内科,甘肃,兰州,730000 
摘    要:目的探讨狼疮性肾炎(LN)患者尿单核-巨噬细胞趋化蛋白-1(MCP-1)和转化生长因子-β1 (TGF-β1)检测的临床意义。方法对57例经肾活检证实为LN患者的尿MCP-1和TGF-β1水平进行检测,24名健康者为正常对照组。结果与正常对照组比较,57例LN患者尿MCP-1和TGF-β1增高(P〈0.05),LN-Ⅳ型尿MCP-1和TGF-β1明显高于LN-Ⅱ和LN-Ⅲ型(P〈0.05),LN-Ⅴ和LN-Ⅵ型尿MCP-1无改变(P〉0.05),而尿TGF-β1增高(P〈0.05);在活动期和非活动期LN患者尿MCP-1和TGF-β1水平高于正常对照组(P〈0.01),活动期尿MCP-1和TGF-β1水平明显高于非活动期(P〈0.05);LN-Ⅳ型尿MCP-1和TGF-β1水平与24 h尿蛋白定量、血肌酐呈明显正相关(r=0.621、0.711,P〈0.05;r=0.568、0.631,P〈0.05)。LN-Ⅱ、LN-Ⅲ、LN-Ⅴ、LN-Ⅵ型尿MCP-1和TGF-β1与24 h尿蛋白定量和血肌酐无明显相关性(P〉0.05);尿MCP-1水平与肾脏活动指数成正相关(r=0.681,P〈0.05),尿TGF-β1与慢性化指数密切相关(r=0.605,P〈0.05)。结论尿MCP-1和TGF-β1水平可作为反映LN病情变化,判断病理类型的重要指标。

关 键 词:单核-巨噬细胞趋化蛋白-1  转化生长因子-β1  狼疮性肾炎

Detection and clinical significance of monocyte chemoattractant protein-1 and transforming growth factor-beta in urine of lupus nephritis
Su Jun-xia,LIANG Zhao-hong,LIU Tian-xi,WANG Rong-zhen.Detection and clinical significance of monocyte chemoattractant protein-1 and transforming growth factor-beta in urine of lupus nephritis[J].Journal of Lanzhou Medical College,2009,35(3):68-71.
Authors:Su Jun-xia  LIANG Zhao-hong  LIU Tian-xi  WANG Rong-zhen
Institution:(Department of Nephrology, First Hospital of Lanzhou University, Lanzhou 730000, China)
Abstract:Objective To investigate clinical significance of urinary monocyte chemoattractant protein-1 (MCP-1) and transforming growth factor-beta (TGF-β1) in patients with lupus nephritis (LN). Methods 57 patients with LN were selected in this study, and 24 healthy people as control. All the level of urinary MCP-1 and TGF-β1 were detected by ELISA. Results In 57 patients with LN, the levels of urinary MCP-1 and TGF-β1 were significantly increased in class LN-Ⅱ, LN-Ⅲ and LN-Ⅳ compared with those of the control(P 〈0.05), and they were more higher in LN-Ⅳ than those in LN-Ⅱ and LN-Ⅲ (P 〈0.05). There was no difference between the levels of urinary MCP-1 in LN-Ⅴ and LN-Ⅵ and those of the control, but the levels of urinary TGF-β1 in LN-Ⅴ and LN-Ⅵ were significantly increased compared with the controls (P 〈0.05).The levels of urinary MCP-1 and TGF-β1 were significantly increased in active phase compared with remission phase, but still higher in remission phase than those in control (P 〈0.05). The levels of urinary MCP-1 and TGF-β1 in class LN-Ⅳ were positively correlated with 24 h urinary protein quantitative determination (r=0.621, P 〈0.05; r=0.711, P 〈0.05); and were positively correlated with serum creatinine(r=0.568, P 〈0.05; r=0.631, P 〈0.05). No correlation was found in other classification. MCP-1 in urine was positively correlated with SLEDAI (r=0.681, P 〈0.05); and TGF-β1 in urine was positively correlated with chronic index (r=0.605, P 〈0.05). Conclusion The levels of urinary MCP-1 and TGF-β1 can be used as an important predictor to assess disease activity, to estimate pathological type change in LN.
Keywords:monocyte chemoattractant protein-I  transforming growth factor-βl  lupus nephritis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号